ArticlePharmaceutics2021

Development and Characterization of Inhaled Ethanol as a Novel Pharmacological Strategy Currently Evaluated in a Phase II Clinical Trial for Early-Stage SARS-CoV-2 Infection.

Ana Castro-Balado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.